Practical Cardiology

It's the Level of the Block that Counts
Can Follow-up Hemodynamic Variables Predict Outcome in PAH?Results of a new study suggest that stroke volume index may be the better hemodynamic variable to monitor in PAH – not cardiac index.
Federal program aimed at reducing readmissions raises concernsA new study has shocking findings about death rates in heart failure patients enrolled in the Hospital Readmissions Reduction Program.
Can Follow-up Hemodynamic Variables Predict Outcome in PAH?Results of a new study suggest that stroke volume index may be the better hemodynamic variable to monitor in PAH – not cardiac index.
Will PRESERVE Trial Results Shift Practice in Renal Prophylaxis?Results of the large trial, unveiled at AHA 2017, appear indisputable, but will prophylaxis with sodium bicarb and acetylcysteine yield ground?
5 Stubborn Statin Myths vs Data that Refute ThemAt AHA.17, Dr Rory Collins offered large-scale trial data to help dispel dangerous disinformation still circulating about the effects of statins.
2017 ACC/AHA Hypertension Guidelines: Case StudyClick through this short case study for an illustration of the key principles put forth in the revised ACC/AHA guidelines on hypertension diagnosis and management.
Cardiologists Talk Concrete Application of Artificial IntelligenceTwo cardiologists respected for their technological expertise took the concept of AI from blue sky to concrete clinical examples at AHA 2017.
New 2017 ACC/AHA Hypertension Guidelines, At-a-GlanceA shift to earlier intervention and emphasis on basics like proper BP measurement and intensive lifestyle change are the key revisions.
Evolocumab Impact Significant in Patients with PADLowering LDL-C levels in FOURIER trial patients with PAD had a significant impact on both MACE and MALE.